InvestorsObserver
×
News Home

Will Vigil Neuroscience Inc (VIGL) Stay at the Bottom of the Healthcare Sector?

Monday, November 27, 2023 02:03 PM | InvestorsObserver Analysts

Mentioned in this article

Will Vigil Neuroscience Inc (VIGL) Stay at the Bottom of the Healthcare Sector?

Vigil Neuroscience Inc (VIGL) is near the bottom in its sector according to InvestorsObserver. VIGL gets an overall rating of 1. That means it scores higher than 1% of stocks. Vigil Neuroscience Inc gets a 24 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

Overall Score - 1
VIGL has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on VIGL!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 1 would rank higher than 1 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Vigil Neuroscience Inc Stock Today?

Vigil Neuroscience Inc (VIGL) stock has gained 8.06% while the S&P 500 has fallen -0.03% as of 2:03 PM on Monday, Nov 27. VIGL is higher by $0.25 from the previous closing price of $3.10 on volume of 128,253 shares. Over the past year the S&P 500 is higher by 14.98% while VIGL has fallen -72.65%. VIGL lost -$2.04 per share the over the last 12 months. Click Here to get the full Stock Report for Vigil Neuroscience Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App